Zoran Culig
Zoran Culig
Professor of Experimental Urology, Medical University of Innsbruck
Bestätigte E-Mail-Adresse bei i-med.ac.at - Startseite
TitelZitiert vonJahr
Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor
Z Culig, A Hobisch, MV Cronauer, C Radmayr, J Trapman, A Hittmair, ...
Cancer research 54 (20), 5474-5478, 1994
11451994
Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone.
Z Culig, A Hobisch, MV Cronauer, AC Cato, A Hittmair, C Radmayr, ...
Molecular endocrinology 7 (12), 1541-1550, 1993
5291993
Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor
A Hobisch, IE Eder, T Putz, W Horninger, G Bartsch, H Klocker, Z Culig
Cancer research 58 (20), 4640-4645, 1998
4781998
Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system
Z Culig, J Hoffmann, M Erdel, IE Eder, A Hobisch, A Hittmair, G Bartsch, ...
British journal of cancer 81 (2), 242, 1999
3881999
Regulation of prostatic growth and function by peptide growth factors
Z Culig, A Hobisch, MV Cronauer, C Radmayr, A Hittmair, J Zhang, ...
The Prostate 28 (6), 392-405, 1996
3611996
Distant metastases from prostatic carcinoma express androgen receptor protein
A Hobisch, Z Culig, C Radmayr, G Bartsch, H Klocker, A Hittmair
Cancer research 55 (14), 3068-3072, 1995
3371995
Interleukin-6 and prostate cancer progression
PC Smith, A Hobisch, DL Lin, Z Culig, ET Keller
Cytokine & growth factor reviews 12 (1), 33-40, 2001
3042001
Interleukin‐6 regulation of prostate cancer cell growth
Z Culig, H Steiner, G Bartsch, A Hobisch
Journal of cellular biochemistry 95 (3), 497-505, 2005
3002005
Prevention and early detection of prostate cancer
J Cuzick, MA Thorat, G Andriole, OW Brawley, PH Brown, Z Culig, ...
The lancet oncology 15 (11), e484-e492, 2014
2622014
Androgen receptors in prostate cancer.
Z Culig, H Klocker, G Bartsch, A Hobisch
Endocrine-related cancer 9 (3), 155-170, 2002
2502002
Immunohistochemical localization of interleukin‐6 and its receptor in benign, premalignant and malignant prostate tissue
A Hobisch, H Rogatsch, A Hittmair, D Fuchs, G Bartsch Jr, H Klocker, ...
The Journal of pathology 191 (3), 239-244, 2000
1932000
Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides
IE Eder, Z Culig, R Ramoner, M Thurnher, T Putz, C Nessler-Menardi, ...
Cancer gene therapy 7 (7), 997, 2000
1912000
Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein …
T Putz, Z Culig, IE Eder, C Nessler-Menardi, G Bartsch, H Grunicke, ...
Cancer research 59 (1), 227-233, 1999
1861999
Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205
M Puhr, J Hoefer, G Schäfer, HHH Erb, SJ Oh, H Klocker, I Heidegger, ...
The American journal of pathology 181 (6), 2188-2201, 2012
1732012
Androgen receptor status of lymph node metastases from prostate cancer
A Hobisch, Z Culig, C Radmayr, G Bartsch, H Klocker, A Hittmair
The Prostate 28 (2), 129-135, 1996
1701996
The mutational landscape of prostate cancer
CE Barbieri, CH Bangma, A Bjartell, JWF Catto, Z Culig, H Grönberg, ...
European urology 64 (4), 567-576, 2013
1692013
Expression, structure, and function of androgen receptor in advanced prostatic carcinoma
Z Culig, A Hobisch, A Hittmair, H Peterziel, ACB Cato, G Bartsch, ...
The Prostate 35 (1), 63-70, 1998
1671998
Inhibition of the acetyltransferases p300 and CBP reveals a targetable function for p300 in the survival and invasion pathways of prostate cancer cell lines
FR Santer, PPS Höschele, SJ Oh, HHH Erb, J Bouchal, IT Cavarretta, ...
Molecular cancer therapeutics 10 (9), 1644-1655, 2011
1622011
Interleukin‐6 activates PI3K/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival
B Wegiel, A Bjartell, Z Culig, JL Persson
International journal of cancer 122 (7), 1521-1529, 2008
1572008
Adipose tissue–derived mesenchymal stem cells expressing prodrug-converting enzyme inhibit human prostate tumor growth
IT Cavarretta, V Altanerova, M Matuskova, L Kucerova, Z Culig, C Altaner
Molecular Therapy 18 (1), 223-231, 2010
1552010
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20